Introduction: Anti-idiotype vaccines are an advanced immunotechnology approach that uses antibodies directed against the antigen-binding site (idiotype) of another antibody to mimic the original antigen. For M.Pharm students, understanding anti-idiotype vaccines involves both immunological theory—Jerne’s idiotype network—and practical aspects such as production of monoclonal anti-idiotype (Ab2) antibodies, characterization of internal-image properties, adjuvant selection, and clinical translation challenges. These vaccines can present conformational or non-protein epitopes, potentially converting T-independent antigens into T-dependent immunogens. This quiz collection covers mechanistic principles, laboratory methods, advantages, limitations and real-world applications to prepare you for advanced coursework and research in vaccine design.
Q1. What best describes an anti-idiotype vaccine?
- Vaccine composed of anti-idiotype antibodies (Ab2) that mimic the original antigen’s epitope and induce protective immune responses
- Vaccine made from inactivated whole pathogens that express idiotypic proteins
- Small-molecule vaccine that inhibits idiotype–anti-idiotype interactions
- DNA vaccine encoding the variable region of the antigen
Correct Answer: Vaccine composed of anti-idiotype antibodies (Ab2) that mimic the original antigen’s epitope and induce protective immune responses
Q2. Which immunological theory primarily underpins the concept of anti-idiotype vaccines?
- Jerne’s idiotypic network hypothesis
- Clonal selection theory
- Danger model
- Hygiene hypothesis
Correct Answer: Jerne’s idiotypic network hypothesis
Q3. How are anti-idiotype antibodies (Ab2) commonly classified based on their relationship to the original antigen?
- Ab2β carry an internal-image of the antigen; Ab2α bind idiotopes outside the paratope; Ab2γ bind the paratope but do not mimic the antigen
- Ab2α are always neutralizing; Ab2β are non-binding; Ab2γ are glycosylated isoforms
- Ab2 types are classified by isotype: IgG, IgM, IgA
- All Ab2 antibodies are functionally identical and not subdivided
Correct Answer: Ab2β carry an internal-image of the antigen; Ab2α bind idiotopes outside the paratope; Ab2γ bind the paratope but do not mimic the antigen
Q4. What is the principal mechanism by which an Ab2-based anti-idiotype vaccine generates immunity against the original antigen?
- Immunization with Ab2 induces anti-anti-idiotype antibodies (Ab3) that recognize and neutralize the original antigen
- Ab2 directly neutralizes the pathogen by binding its surface proteins
- Ab2 vaccines function solely by activating complement without inducing adaptive responses
- Ab2 vaccines mediate T-cell deletion of antigen-specific clones
Correct Answer: Immunization with Ab2 induces anti-anti-idiotype antibodies (Ab3) that recognize and neutralize the original antigen
Q5. Which of the following is a key advantage of anti-idiotype vaccines compared with using the native antigen?
- They can mimic non-protein antigens (e.g., carbohydrates, glycolipids) and thereby generate T-dependent responses
- They always produce a stronger cytotoxic T-lymphocyte response than peptide vaccines
- They are universally effective without adjuvants
- They require only a single dose for life-long immunity
Correct Answer: They can mimic non-protein antigens (e.g., carbohydrates, glycolipids) and thereby generate T-dependent responses
Q6. What is a major practical limitation in the development and manufacture of anti-idiotype vaccines?
- Complex production and characterization of monoclonal Ab2s leading to batch-to-batch variability and regulatory challenges
- Complete lack of methods to test Ab2 specificity
- Inability to scale up using cell-culture systems
- Guaranteed induction of autoimmunity in all recipients
Correct Answer: Complex production and characterization of monoclonal Ab2s leading to batch-to-batch variability and regulatory challenges
Q7. Which technique has been the classical method to generate monoclonal anti-idiotype antibodies for vaccines?
- Hybridoma technology (fusion of antigen-specific B cells with myeloma cells)
- CRISPR-mediated in vivo B-cell editing
- Direct chemical synthesis of full-length antibodies
- Passive diffusion selection
Correct Answer: Hybridoma technology (fusion of antigen-specific B cells with myeloma cells)
Q8. In the context of B‑cell lymphomas, what does the term “idiotype” most specifically refer to?
- The unique variable-region (V region) antigenic determinants of the tumor immunoglobulin expressed on malignant B cells
- The conserved Fc region of IgG antibodies produced by the tumor
- A non-specific tumor-associated carbohydrate antigen
- The host’s HLA haplotype that presents tumor peptides
Correct Answer: The unique variable-region (V region) antigenic determinants of the tumor immunoglobulin expressed on malignant B cells
Q9. Which experimental evidence most convincingly demonstrates that an Ab2 behaves as an “internal image” of the antigen?
- Immunization with the Ab2 induces Ab3 antibodies that bind the original antigen and compete with Ab1 for binding
- Ab2 shows a different molecular weight than Ab1 on SDS-PAGE
- Ab2 is glycosylated while Ab1 is not
- Ab2 enhances complement activation in vitro
Correct Answer: Immunization with the Ab2 induces Ab3 antibodies that bind the original antigen and compete with Ab1 for binding
Q10. Which adjuvant is commonly accepted for use in human anti-idiotype vaccine formulations?
- Aluminum salts (alum)
- Freund’s complete adjuvant
- Polyethylene glycol (PEG) alone
- Live attenuated bacteria
Correct Answer: Aluminum salts (alum)
Q11. What is one major advantage of using phage-display libraries to isolate anti-idiotype fragments?
- Enables rapid selection of human or humanized Ab2 fragments and epitope mapping without immunizing animals
- Guarantees generation of full-length IgG with effector functions
- Does not require knowledge of the idiotope sequence
- Automatically produces glycosylated antibodies
Correct Answer: Enables rapid selection of human or humanized Ab2 fragments and epitope mapping without immunizing animals
Q12. Which laboratory assay is most routinely used to detect whether immunization with an anti-idiotype vaccine has induced Ab3 that bind the original antigen?
- ELISA measuring serum binding to the original antigen
- Northern blot for messenger RNA expression
- Mass spectrometry of serum proteins
- Gram staining of peripheral blood smears
Correct Answer: ELISA measuring serum binding to the original antigen
Q13. Which safety concern is specifically relevant to anti-idiotype vaccine strategies?
- Potential induction of autoimmunity due to molecular mimicry between the internal-image and host self-antigens
- Instantaneous reverse mutation of host B cells
- Guaranteed transmission of infectious agents via Ab2 preparations
- Permanent depletion of all memory B cells
Correct Answer: Potential induction of autoimmunity due to molecular mimicry between the internal-image and host self-antigens
Q14. Anti-idiotype antibodies that serve as “internal image” antigens are effectively functioning as which of the following?
- Surrogate antigens that structurally or functionally mimic the original epitope
- Non-specific immunosuppressive molecules
- Primary antigen-presenting cells
- Complement inhibitors
Correct Answer: Surrogate antigens that structurally or functionally mimic the original epitope
Q15. Which anti-idiotype vaccine was developed and clinically evaluated against the ovarian cancer antigen CA-125?
- Abagovomab
- Racotumomab (1E10)
- BCG-idiotype
- Influenza anti-idiotype
Correct Answer: Abagovomab
Q16. From a regulatory perspective, what is a critical requirement when developing an anti-idiotype vaccine for clinical use?
- Robust potency and identity assays demonstrating consistent Ab2 biological activity and batch comparability
- Exemption from sterility testing because antibodies are sterile by nature
- Single-animal toxicity studies only, with no need for GMP manufacturing
- No requirement for immunogenicity testing in humans
Correct Answer: Robust potency and identity assays demonstrating consistent Ab2 biological activity and batch comparability
Q17. Which formulation strategy can enhance helper T-cell responses to anti-idiotype vaccines that mimic T-independent epitopes?
- Conjugation of the Ab2 to a carrier protein (e.g., KLH) or inclusion of universal T-helper epitopes
- Removing all Fc regions to prevent T-cell recognition
- Administering Ab2 solely via oral route without adjuvant
- Using only short synthetic peptides with no carrier
Correct Answer: Conjugation of the Ab2 to a carrier protein (e.g., KLH) or inclusion of universal T-helper epitopes
Q18. Which assay is most appropriate to quantify antigen-specific T-cell responses elicited by an anti-idiotype vaccine?
- IFN-γ ELISPOT using antigen-stimulated peripheral blood mononuclear cells
- Serum creatinine measurement
- Urine culture
- Gram staining of lymph node aspirates
Correct Answer: IFN-γ ELISPOT using antigen-stimulated peripheral blood mononuclear cells
Q19. Anti-idiotype vaccines are especially useful for targeting which class of antigens in oncology?
- Tumor-associated self-antigens that are poorly immunogenic in their native form
- Highly immunogenic viral proteins only
- Intracellular metabolic enzymes that cannot be surface-exposed
- Non-immunogenic inorganic compounds
Correct Answer: Tumor-associated self-antigens that are poorly immunogenic in their native form
Q20. What is a common cause of failure when an anti-idiotype vaccine does not protect despite generating Ab3 responses?
- The induced Ab3 recognize epitopes that do not neutralize or are different from the protective epitope on the original antigen
- The Ab3 are always too high affinity and cause immune complex disease
- Ab3 always convert into regulatory T cells preventing immunity
- Ab3 cannot be detected by standard immunoassays
Correct Answer: The induced Ab3 recognize epitopes that do not neutralize or are different from the protective epitope on the original antigen
